• Experience in conducting global clinical trials by managing multi-functional international study teams in adherence to ICH Guidelines and other applicable regulations
  • Expertise in the design, feasibility assessment, and planning of single and multi-center Phase I-IV clinical trials
  • Experience in compiling and writing technical documents such as investigational drug brochures, protocols, informed consents, and clinical study reports
  • Expertise in qualifying, selecting, training, managing field-based study monitors and medical monitors against clinical trial needs
  • Expertise in creating and implementing Monitoring, Audit, Data Management, and Trial Master File plans
  • Expertise in investigational drug accountability procedures including for controlled substances

MSA News

Mesa Science Associates Receives Grant to Begin Study of a Treatment for Marfan Syndrome

Mesa Science Associates Inc. (MSA) received a Phase I Small Business Innovative Research Grant (SBIR) from the National Institutes of…

Read More

NIH SBIR Grant application 1/5/2022

Mesa Science Associates has applied for an NIH Small Business Innovative Research (SBIR) Grant from the National Institutes of Health…

Read More

Mesa Green Caine Study Results Reported at Epilepsy Conference

Mesa Science Associates Inc. (MSA) and Mesa Green Pharma LLC (MGP) are pleased to announce the results of a study…

Read More